(Natural News) Clinical trials of the world’s first malaria vaccine are scheduled to begin next year in three African countries – Kenya, Ghana and Malawi – but a number of questions remain regarding the vaccine’s efficacy and whether or not the program is actually part of a globalist-funded depopulation campaign.
Despite decades of fighting the disease through a variety of methods, malaria still claims nearly half a million victims per year – 92 percent of them in Africa. Most of the deaths occur among children.
That’s why many people, including Matshidiso Moeti, WHO regional director for Africa, have heralded the prospect of a malaria vaccine as “great news.” But upon closer inspection, the scheme doesn’t appear to be all that great after all.
The malaria vaccine – called RTS,S – was developed through a partnership between PATH and GlaxoSmithKline, with funding provided by (surprise!) the Bill and Melinda…
View original post 501 more words